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Recent studies from our laboratory
have shown that treating BN rats with
HgCl2 causes a decrease in peripheral
RT6+ T-lymphocytes, a change that coin-
cides with the appearance of circulating
autoantibodies to renal antigens (17). We
have proposed that autoimmune kidney
disease induced by mercury in genetically
susceptible rats may be a consequence of
interactions between this metal and a sub-
set of regulatory (RT6+?) T-cells. In con-
trast, Lewis (LEW) rats are resistant to the
autoimmune effects ofmercury and report-
edly develop a subpopulation ofsuppressor
T-lymphocytes (18,19). Therefore, it was
of interest to compare the effects of mer-
cury on lymphocyte subpopulations from
BN, LEW, and (BN x LEW) F1 rats. The
hybrids between the mercury-susceptible
BN and the mercury-resistant LEW strain
are susceptible to the autoimmune effects
of HgCl2, a trait inherited in a dominant
fashion (4). We show here that LEW rats
injected with HgCI2 do not have signifi-
cant decreases in RT6+ T-lymphocytes or
detectable autoimmune responses. In-
stead, both BN and (BN x LEW) F1
hybrid rats experience autoimmune re-
sponses to renal antigens as well as similar
changes in RT6+ T-cells after mercury
treatment.
Methods
We obtained 107 female rats [39 LEW, 36
(BN), and 32 (BN x LEW) Fl hybrids,
hereafter referred to as F, hybrids] from a
commercial source (Harlan Sprague Daw-
ley, Indianapolis, IN). All animals were
housed in plastic cages with wood shav-
ings, in an automated light cycle environ-
ment (12:12 hr) and received standard rat
diet and water adlibitum. Treatment ofall
rats followed the standard National Insti-
tutes ofHealth guidelines: light ether anes-
thesia was used for all procedures, includ-
ing bleeding from the retro-orbital plexus
or exsanguination followed by transection
of the thoracic aorta at the termination of
the experiments.
Previous studies have shown that treat-
ment with mercury in its various chemical
forms, using different routes ofadministra-
tion (subcutaneous injection, oral inges-
tion, inhalation), results in autoimmune
responses to a variety of antigens (7-10).
Relatively low doses of mercury have been
found to be effective in both rats and mice;
for example, the immunotoxic effects of
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HgCI2 occur in BN rats at doses (3-25
,g/100 g body weight) that are much
lower than those causing the common
nephrotoxic effects (11,12, Bigazzi et al.,
unpublished data). However, in the exper-
iments reported here, we used higher levels
of HgCl2 (100 ,ug/100 g body weight) to
replicate the doses used in previous studies
ofBN and LEW rats (17,18,20).
BN, LEW, and F1 rats were randomly
divided into experimental and control
groups and treated with mercury or water,
respectively, as previously described (17).
We injected 80 experimental rats (31
LEW, 25 BN, and 24 F1 hybrids) subcuta-
neously on the abdomen with 0.1 ml of a
mercuric chloride solution (HgCl2, 1
mg/ml) per 100 g body weight. We dis-
solved HgCl2 in distilled water and record-
ed the pH before use (range 3.9-4.2). Rats
were injected under light ether anesthesia.
We injected rats three times a week for 2
weeks, for a total administration of600 ,ug
HgCI2/100 g body weight/rat. Four LEW
rats died under ether anesthesia and one F1
hybrid injected with mercury died on day
12 ofmercury treatment: these animals are
not included in the Results section. We
anesthetized and injected 27 control rats (8
LEW, 11 BN, and 8 F1 hybrid ofsame age
and weight as those injected with mercury)
with distilled water at pH 4.2 (acidified by
adding 0.01 N HCI) following the same
regimen.
ELISA for circulating autoantibodies to
renal GBM and anti-laminin antibodies
was performed as previously described
(17). In brief, we incubated sera from
mercury-treated and control rats in ELISA
plates that had been coated previously with
rat GBM or mouse laminin (500 ng/well).
After incubation and washing, horseradish
peroxidase-conjugated rabbit antibodies to
rat IgG Uackson ImmunoResearch Labor-
atories, Inc., West Grove, PA) were used to
detect the binding of rat anti-GBM to
GBM (or anti-laminin to laminin). We
read plates using a Titertek ELISA Reader
at OD414.
We determined rat IgG bound to renal
GBM and tubular basement membrane
(TBM) by direct immunofluorescence as
previously described (17). In brief, cryo-
stat sections of rat kidney were stained
with fluoroscein isothiocyanate (FITC)-
conjugated rabbit antibodies to rat IgG
(Sigma Chemical Company, St. Louis,
MO) diluted 1:20 in phosphate-buffered
saline. We read the sections using a Leitz
Dialux fluorescence microscope equipped
with epi-illumination.
As previously described (17), spleen,
lymph node, and thymus cell suspensions
were obtained by gently pressing the tissues
through a stainless-steel screen (50 mesh).
The six proximal cervical lymph nodes
were recovered for total cell counts and
subset analysis in all experiments. We
washed the cells in two changes of cold
medium (RPMI 1640) and determined cell
viability by trypan blue exclusion. Cell
suspensions were labeled with anti-RT6.2
or anti-RT6.1 rat monoclonal antibodies
(mAb) and developed for immunofluores-
cence with an F(ab')2 fragment of an
FITC-conjugated goat anti-rat IgG (heavy
and light chain specific; Caltag Laborator-
ies, San Francisco, CA). Controls included
the FITC conjugate alone and "irrelevant"
primary rat mAb developed with the same
secondary reagent: values obtained from
these controls represent surface Ig-positive
(B) lymphocytes and were subtracted from
the counts ofRT6+ cells. When cells were
labeled with mouse mAb directed against
other cell surface markers (CD4, CD5,
CD8, etc., see below), we developed them
with an F(ab')2 fragment ofan FITC-con-
jugated goat anti-mouse IgG antibody that
had been absorbed by affinity chromatog-
raphy on a rat IgG column to remove
cross-reacting antibodies. Controls rou-
tinely included the FITC conjugate alone
and irrelevant mouse mAb. Cell suspen-
sions were fixed before flow cytometry
using saline-buffered 10% formalin and
then analyzed using a fluorescence-activat-
ed cell sorter IV (Becton Dickinson,
Mountain View, CA), according to relative
low-angle light scatter and relative fluores-
cence intensity as described previously
(21,22). We excluded dead cells and cont-
aminating red blood cells from analysis by
electronic gating. At least 50,000 nucleated
cells were analyzed for relative fluorescence
intensity.
Hybridoma cell lines secreting mAb to
the RT6.1 (clone DS4.23) and RT6.2
(clone 6A5) alloantigens are maintained in
our laboratory (21,22). Clone DS4.23 was
developed in the laboratory of Frank Fitch
in collaboration with Lubaroffand Greiner
(23). The 6A5 cell line was a gift of D.M.
Lubaroffofthe University ofIowa and was
originally developed and characterized by
B. Carpenter of Harvard University (24,
25). The RT6 alloantigenic system in the
rat is not linked to the MHC and consists
of two alloantigens, RT6.1 (expressed in
rats of the Lewis and PVG strains) and
RT6.2 (expressed in rats of the Brown
Norway and Wistar Furth strains) (17)'
The RT6 antigen is expressed only by T-
lymphocytes and approximately 45% of
CD4+ and 70% ofCD8+ peripheral T-cell
subsets. No RT6+ thymocytes, bone mar-
row lymphocytes, or B-lymphocytes have
been detected, nor has RT6 been identified
on other tissues, including brain tissue.
RT6+ T-cell subsets are severely decreased
in diabetes-prone BB rats (i.e., animals that
spontaneously develop insulin-dependent
diabetes mellitus, both clinically and bio-
chemically analogous to human diabetes
mellitus) (26,27). Different lines of BB
rats have been developed, one called "dia-
betes-prone" (DP) and one called "dia-
betes-resistant" (DR). In vivo depletion of
RT6+ cells induces diabetes in 50% of DR
BB rats (28). Lymphocyte transfers from
DR to DP rats prevent diabetes mellitus,
and this protection is associated with the
persistence of donor-origin RT6+ T-cells
(29). In addition, concanavalin A-activat-
ed spleen cells from RT6-depleted PVG or
Yoshida rats can transfer insulitis and/or
thyroiditis to histocompatible athymic
recipients (30).
We obtained MAb to additional rat
lymphocyte markers from Seralab, Ac-
curate Chemical & Scientific Corporation
(Westbury, NY) and Harlan Bioproducts
for Science, Inc. (Indianapolis, IN): MRC
OX-19 (anti-CD5, pan-T-cells), R7.3
(anti-TCRap), MRC OX-8 (anti-CD8 T-
cell subset and natural killer cells), W3/25
(anti-CD4 T-cell subset and monocytes),
MRC OX-39 (anti-IL-2 receptor), MRC
OX-4 (anti-common class II MHC).
We obtained the total number ofRT6+
lymphocytes from their percentage of the
total cell numbers in spleen or lymph
nodes. Then we calculated the total num-
ber of RT6- cells by subtracting the total
number ofRT6+ lymphocytes from total T
(CD5+) cell numbers. Finally, we ob-
tained the RT6- to RT6+ ratio by dividing
the total number of RT6.1- or RT6.2- T-
lymphocytes by the total number of
RT6.1+ or RT6.2+ lymphocytes.
All ELISAs were performed in dupli-
cate, and the data obtained are expressed as
means ± SEM. Flow cytometric analysis
was performed on single samples from each
rat, and the data from all experimental (or
control) groups are expressed as means ±
SEM. We statistically evaluated results
obtained by ELISA and flow cytometry by
one-way analysis of variance (ANOVA),
followed by post-hoc means tests (Fisher's
Protected Least Significance Difference,
Scheffe's S, Games-Howell, and Dunnett's
multiple comparison procedures). Two
computer programs (StatView II and
SuperANOVA, Abacus Concepts, Inc.,
Berkeley, CA) were used for this purpose.
Results
Autoimmune Responses to Renal
Antigens
We first examined the effects ofmercury in
two matching groups of LEW and BN
rats, treated with mercury ("experimental")
or injected with water ("control") and sac-
rificed on day 16 of treatment, i.e., the
time when autoimmune responses to renal
antigens are known to be at their peak in
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Table 1. Autoimmune responsesto laminin and renal immunopathology in rats treated with mercury
% Rats
with serum % Rats
Serum antibodies antibodies with renal
No. of to laminina to laminina Ig depositsb
Strain rats Treatment Day 0 Day 16 (Day 16) (Day 16)
LEW 7 HgCI2 0.093±0.006 0.106±0.005 0 0
4 H20 0.093 ± 0.009 0.104± 0.007 0 0
BN 7 HgCI2 0.118±0.006 0.289±0.035* 86 100
4 H20 0.102±0.018 0.136±0.010 0 0
(BN x LEW) F1 24 HgCI2 0.065±0.003 0.182±0.018** 83 100
8 H20 0.075 ±0.007 0.077 ±0.007 0 0
aDetermined by ELISA (data are expressed as mean OD414 ± SEM).
Determined by direct immunofluorescence.
*Statistically significant compared to H20-treated controls (p = 0.0106).
** Statistically significant when
compared to H20-treated controls (p = 0.0055).
BN rats (14,1/). None ofthe experimental
LEW rats developed antibodies to laminin
(Table 1) or to renal GBM (data not
shown). On the other hand, approximately
86% of experimental BN rats produced
antibodies to laminin (Table 1).
Autoantibodies to rat GBM were also de-
tected by ELISA in the sera ofthe same ani-
mals (data not shown). None of the con-
trol rats (LEW or BN) produced auto-anti-
bodies to GBM or laminin. To ensure that
the choice ofthe timing ofobservation (day
16) had no negative influence on our
results, we performed a kinetic study in
another group of LEW rats and sacrificed
them at regular intervals (days 12, 16, 23,
and 30) during their exposure to mercury.
Again, none of these animals produced
autoantibodies to GBM or laminin. For
example, there were no statistical differences
in the anti-GBM ELISA values ob-tained
with sera from control (0.211 ± 0.021) or
experimental rats (day 12 = 0.271 ± 0.114;
day 16 = 0.235 ± 0.040; day 23 = 0.288 ±
0.104; day 30 = 0.238 + 0.052). Instead,
sera from experimental BN rats contained
autoantibodies to rat GBM (0.606 ± 0.032).
These findings confirm that rats ofthe LEW
strain are resistant to mercury-induced
autoimmunity, as previously reported by
other investigators (4).
We then investigated the autoimmune
consequences ofexposure to mercury in Fl
hybrid rats. Antibodies to laminin were
present in the sera of 83% ofexperimental
animals (Table 1). Autoantibodies against
rat GBM were found in the same sera (data
not shown). None ofthe control rats pro-
duced autoantibodies to GBM or laminin.
These serological observations were con-
firmed by renal immunopathology data.
Direct immunofluorescence of kidney sec-
tions revealed rat immunoglobulins bound
in a linear fashion to renal GBM and TBM
in 100% of experimental BN and F1 hy-
brids, whereas all experimental LEW rats
gave negative results (Table 1). All control
animals were also negative. Our observa-
tions confirm previous reports that rats
from the BN strain and their F1 hybrids
with resistant strains are susceptible to mer-
cury-induced autoimmunity (4). Therefore,
these animals provide an excellent model to
determine possible changes in regulatory T-
lymphocytes ofthe RT6+ subpopulation.
Phenotypic Analysis ofLymphocyte
Subpopulations in LEWRats
Lymphocytes from spleens and cervical
lymph nodes of experimental and control
LEW rats, sacrificed at various intervals
during treatment (days 12, 16, 23, and 30),
were counted and examined by flow cytom-
etry for a variety of surface markers, with
the following results.
As shown in Table 2 and Figure 1,
experimental LEW rats had a moderate but
significant increase in numbers of spleen
and lymph node cells. Higher spleen cell
numbers were noted on days 12, 16, and
23 of treatment (93% in-crease, p =
0.0518, 86%, p = 0.0065 and 108%, p =
0.0289, respectively). Lymph nodes also
contained higher numbers of cells on days
16 (232% increase, p = 0.0004) and 23
(46%, p = 0.0846).
There were no significant differences
in percentage of RT6+ cells from the
spleens of control and experimental LEW
rats on days 12, 16, and 23 (Table 2).
Values for day 30 showed a moderate
increase (26%, p = 0.0233). There were
also no percentage changes in lymph
nodes for days 12 and 30, but a slight
decrease was observed on days 16 (12%, p
= 0.0565) and 23 (16%, p = 0.0438). The
total number of RT6.1+ spleen lympho-
cytes showed a moderate increase on each
day of treatment (day 12 = 92%, p =
0.0083; day 16 = 83%, p = 0.0045; day 23
= 112%, p = 0.0018; day 30 = 92%, p =
0.0083), whereas lymph node cells had a
significant change only on day 16 (185%
increase, p = 0.0001). The ratio of RT6-
to RT6+ cells did not usually vary in ex-
perimental animals versus controls, except
for a modest increase (37%, p = 0.0186)
observed in lymph node cells only on day
23. As shown in Figure 2, which com-
pares values obtained from animals ofdif-
ferent strains, there was no significant
change in the RT6 ratio of LEW rats sac-
rificed on day 16.
The percentage ofT-cells did not vary
significantly in experimental versus control
rats. Table 2 provides data obtained with
mAb OX-19 (anti-CD5), but similar
results were also obtained with mAb R7.3
(anti-TCRoa). On the other hand, total
numbers ofT-cells had increases compara-
ble to those observed in total cell numbers
(data not shown). In the spleen, T-cell
numbers were higher on days 12 (99%, p =
0.0442), 16 (65%, p = 0.0425), and 23
(107%, p = 0.0363). In lymph nodes they
increased only on days 16 (224%, p =
0.004) and 23 (48%, p = 0.0763). Percen-
tages ofCD8+ and CD4+ lymphocytes var-
ied little either in spleen or lymph nodes.
Total numbers of CD8+ T-cells did not
change significantly in the spleen but were
258% higher in lymph nodes (p = 0.0009)
Table 2. Lymphocyte subpopulations in control and experimental LEW rats
Treatment
(day of No. of Total no.
sacrifice) rats Cells (x 106) %RT6.1 %T-cells %CD8 %CD4 %B-cells
H20 7 Spleen 127 ±42 26.7± 2.1 59.9± 2.0 28.8±3.7 50.3± 1.5 41.8±3.0
LN 52±7 41.1 ±1.7 75.5±1.0 28.2± 2.1 59.9± 0.9 33.5± 1.4
HgCI2 5 Spleen 246 ±24 26.9±1.7 64.4± 1.3 27.9±1.3 52.2± 0.9 36.6± 0.3
(day 12) LN 66± 10 42.4± 1.2 77.3±1.1 30.0± 1.5 62.6± 0.9 28.8±1.6
HgCI2 11 Spleen 236± 10 26.6± 1.7 54.8±1.6 27.5± 1.6 46.6± 0.9 38.3±1.4
(day 16) LN 173± 21 36.6± 1.7* 73.6±1.2 30.0± 1.4 53.0±1.5 39.2±1.1
HgCI2 5 Spleen 265±25 26.4± 2.0 61.7 ±0.7 28.8 ±3.8 52.3 ±0.9 35.1 ± 1.6
(day23) LN 76±11 35.5± 1.8** 76.1 ±0.6 35.3±1.1 57.1 ±0.8 38.9± 1.7
HgCI2 5 Spleen 195±17 33.7 ± 1.2***61.3± 1.1 26.4± 1.4 51.7± 1.6 34.7 ± 1.2
(day30) LN 69± 12 41.9±1.8 74.7 ±2.5 30.1 ±1.2 56.2± 2.0 36.8± 2.5
LN, lymph nodes. Flow cytometric analysis of spleen and cervical node lymphocytes; data expressed as
means ± SEM.
*Slight statistically significant decrease compared to H20-treated controls (p = 0.0565). **Slight statisti-
cally significant decrease compared to H20-treated controls (p = 0.0438). ***Moderate statistically signif-
icant increase compared to H20-treated controls (p = 0.0233).
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Figure 2. Treatment with HgCI2for 16 days causes an increase in the ratios of RT6- to RT
in both lymph nodes (LN) and spleen (SPL) of BN and (BN X LEW) F1 hybrids. Similarly
experience only minor variations ofthose ratios.
on day 16 and 84% (p = 0.0189) on day
23. Numbers of CD4+ T-cells in both
spleen and lymph nodes showed increases
paralleling those of total cell numbers.
Total numbers of B-cells in-creased in
both spleen and lymph nodes, again paral-
leling the higher total cell numbers.
Finally, numbers of lymphocytes positive
for MHC class II antigens were increased
on days 12, 16 and 23 (data not shown).
In summary, mercury
LEW rats resulted in mod4
cant increases in the numbe
RT6+ T-lymphocytes did not change in a
significant fashion in the spleen and
changed only on day 23 in lymph nodes.
PhenotypicAnalysis ofLymphocyte
Subpopulations in BN Rats
We have previously reported that RT6+ T-
* Ln. cells lymphocytes from spleen and cervical lymph nodes of mercury-treated BN rats
show a relative decrease, particularly evi-
Spi. cells dent in the ratio between RT6- and RT6+
cells (17). In the present series of experi-
ments we examined the phenotypes ofcells
from a new group of experimental and
control BN rats, sacrificed on day 16 (i.e.,
at the time when autoimmune responses to
renal antigens reach their peak in animals
injected with HgCI2), with the following
results.
omegaly and lyi- As shown in Table 3, the number of
rease oftotal cell spleen cells in experimental BN rats was
after 16 days of considerably higher than in controls, a dif-
h BN (spleen, p= ference that was statistically significant
)des,p=0.0001). (218%, p = 0.0033). A more striking
increase in total cell numbers (860%, p =
0.0001) occurred in cervical lymph nodes
(Table 3), confirming previous observa-
tions ofhyperplasia in peripheral lymphoid
tissues from BN rats exposed to mercury
(17,31-33).
After 2 weeks of mercury treatment,
the percentage of RT6+ cells in lymph
nodes was significantly decreased as com-
pared to controls (100%, p = 0.0009),
whereas spleen cells had a less marked
change (55%, p = 0.0062). The total
Water number of RT6.2+ lymphocytes of experi-
mental BN rats was moderately increased
* Mercury in the spleen (78%, p = 0.0578), but was
higher in lymph nodes (307%, p =
0.0033). On the other hand, the total
number of RT6.2- cells was greatly in-
creased and proportionally more than that
of RT6.2+ cells (332%, p = 0.0084 in the
spleen; 572%, p = 0.0602 in lymph
nodes). As a consequence, the ratio of
RT6- to RT6+ positive cells was higher
both in lymph nodes and spleens ofexperi-
mental BN rats (Fig. 2).
In the spleen, there was no significant
change in the percentage of T-cells in
experimental versus control rats (p =
r6+T-lymphocytes 0.2643), but the total numbers of T-cells
treated LEW rats increased by 173% after mercury treat-
ment (p = 0.0045). Similarly, the percent-
age of spleen CD8+ lymphocytes did not
treatment of show major changes (p = 0.3048), but their
est but signifi- total number was increased (316%, p =
r ofspleen and 0.0313). In contrast, CD4+ cells were pre-
lymph node cells, and as a consequence
most subpopulations of lymphocytes were
numerically increased. There were only
slight and sporadic changes in the percent-
age of RT6+ T-cells, but their numbers
were higher in experimental than in con-
trol animals. The ratio between RT6- and
sent in a lower percentage in experimental
BN (38% change, p = 0.0004) but showed
slightly higher numbers (119% change, p =
0.0114). The percentage of B-cells was
not changed (p = 0.337), but their number
increased by 230% (p = 0.002). Lympho-
cytes from cervical lymph nodes gave simi-
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Table 3. Lymphocyte subpopulations in mercury-treated BN and (BN x LEW) F1 hybrids
Total no.
Strain Treatment Cells (x 106) %RT6.1 %RT6.2 %T-cells %CD8 %CD4 %B-cells
BN HgCI2 Spleen 535 ±68 0 14.4± 1.3* 32.6±1.5 15.5 ±1.6 28.5±1.1 47.2±1.4
LN 484±50 0 22.0± 2.8** 34.0± 2.8 11.7 ± 2.0 32.4±1.5 49.8±3.4
H20 Spleen 168±23 0 22.3±2.4 35.9±2.4 12.4±2.1 39.3±2.9 44.8±1.6
LN 50±13 0 44.0± 5.9 64.0±1.4 6.3± 0.4 54.4±1.5 30.9±1.6
(BNxLEW)F1 HgCI2 Spleen 397±33 13.1 ±0.5*** 17.2±0.6*** 38.2±0.7 19.6±0.6 31.0±1.7 54.5±1.1
LN 580 ±42 22.1 ± 1.4*** 29.9± 1.6*** 45.2± 1.4 17.5 ± 1.0 37.2± 1.3 51.0± 1.7
H20 Spleen 223±30 27.5±2.1 37.7±2.0 47.4±1.7 14.6±0.8 40.1 ±1.7 40.3±1.1
LN 41±7 42.4± 1.0 60.3±1.0 70.2±2.3 10.7±0.5 62.3±1.7 20.1 ±1.5
LN, lymph nodes. Atotal of 25 BN (18 experimental and 7 controls) and 32 F1 hybrids (24 experimental and 8 controls) were sacrificed on day 16 from the start of
the experiments. Flow cytometric data are expressed as means ±SEM.
Percentages of RT6.1+ and RT6.2+ T-lymphocytes significantly decreased in HgCI2-treated rats as compared to H20-treated controls: *p = 0.0062; **p = 0.0009;
***p= 0.0001.
lar patterns, with moderate decreases in the
percentage ofT-cells and CD4+ cells (89%
and 68%, p = 0.0001 for both), and signif-
icant increases in their numbers (374%
and 442%, p = 0.0001 for both). On the
other hand, CD8+ cells presented no major
percentage change (p = 0.1083) but had
higher numbers (1625%, p = 0.0167).
Finally, the percentage of B-cells in lymph
nodes increased by 61% (p = 0.0028), and
their number increased by 1417% (p =
0.0003) in experimental BN rats.
In summary, mercury-treated BN rats
showed marked hyperplasia of peripheral
lymphoid organs, significant decreases in
the percentage of RT6+ cells, and propor-
tionally higher numbers of RT6- cells. As
a result, the balance between these two
subpopulations oflymphocytes was altered
in favor of RT6- cells.
PhenotypicAnalysis ofLymphocyte
Subpopulations in F1 Hybrid Rats
Because F1 hybrids between susceptible
BN and resistant LEW rats are also suscep-
tible to mercury-induced autoimmunity,
we determined the phenotype ofperipheral
lymphocytes in experimental or control F
rats, with the following results.
As shown in Table 3 and Figure 1, the
total number ofspleen cells in experimen-
tal F1 rats was increased by 78% as com-
pared to controls (p = 0.01). A more strik-
ing increase in total cell numbers (1315%,
p = 0.0001) occurred in cervical lymph
nodes (Table 3).
The percentage of cells expressing the
RT6 phenotypes was significantly de-
creased in both spleens and lymph nodes
of experimental animals as compared to
controls (Table 3). In the spleen, percent-
ages of RT6.1+ and RT6.2+ were lower by
110% and 1 9% (p = 0.0001 for both).
Similar reductions were observed in lymph
nodes (92% and 102% change, p =
0.0001 for both). The total number of
RT6.1+ and RT6.2+ spleen lymphocytes
did not show significant changes, but RT6-
cells were increased (137%, p = 0.0016 for
RT6.1- and 296%, p = 0.0001 for RT6.2-).
Therefore, the ratios of RT6- to RT6+
spleen cells were increased by 197% for
RT6.1 and 385% for RT6.2 (p = 0.0001
for both; Fig. 2). In cervical lymph nodes
of experimental rats, the total number of
RT6.1+ and RT6.2+ lymphocytes was sig-
nificantly increased (623% and 587%, p =
0.0001 for both). However, RT6- cells
were present in even greater numbers
(1114% change for RT6.1- and 2372% for
RT6.2-, p = 0.0001 for both), resulting in
altered ratios of RT6- to RT6+ cells (Fig.
2). An increase of 89% was observed for
RT6.1-/RT6.1+ (p = 0.0802) and 258%
for RT6.2-/RT6.2+(p = 0.0064).
In the spleens of experimental F, ani-
mals, we observed a 24% decrease in the
percentage of T-cells (p = 0.0001) and a
41% increase in T-cell numbers (p =
0.0766) as compared to controls. Both
percentage and total numbers of spleen
CD8+ lymphocytes were increased (35%, p
= 0.0001 and 140%, p = 0.0021). In con-
trast, CD4+ cells were present in a lower
percentage in the spleen ofexperimental Fl
rats (29% change, p = 0.0063), but their
numbers were not significantly higher (p =
0.1156). Both percentage and number of
spleen B-cells were increased (36%, p =
0.0001 and 142%, p = 0.0038). Lympho-
cytes from cervical lymph nodes gave simi-
lar patterns, with decreases in percentage of
T- and CD4+ cells (55% and 68% change,
p = 0.0001 in both cases) and striking
increases in their numbers (816% and
732%, p = 0.0001 for both). On the other
hand, lymph node CD8+ cells presented
increases both in percentage and numbers
(64%, p = 0.0004 and 2393%, p =
0.0001). Finally, there was a definite
increase of B-lymphocytes in the lymph
nodes of experimental F1 rats: their per-
centages were 154% (p = 0.0001) higher,
and their numbers rose by 3665% (p =
0.0001).
In summary, treatment of F1 hybrids
with mercury resulted in hyperplasia of
peripheral lymphoid tissues similar to that
observed in BN rats under the same cir-
cumstances. In addition, exposure to mer-
cury was followed by significant decreases
of RT6+ and increases of RT6- cells. The
resulting changes in the ratio between
these lymphocyte subpopulations revealed
that mercury had altered their balance.
Thus, F1 hybrids exhibited the same
behavior of their mercury-susceptible
parental strain (BN), both in their autoim-
mune responses to renal antigens and
changes in lymphocyte subpopulations.
Discussion
The existence of T-suppressor cells is one
of the most controversial topics of im-
munology. However, Todd and Steinman
(34) state that "suppressor cells are back in
fashion, since they refuse to go away and
crop up repeatedly in autoimmune diseases
as a plausible explanation for peripheral
tolerance." Previous studies relied exclu-
sively on a few markers (e.g., CD4 and
CD8) as representative of functional
(helper/inducer versus suppressor/ cytotox-
ic, respectively) activities, which may
explain both controversial results and lack
of correlations between T-cell subsets,
severity of autoimmune disease, and/or
kinetics of autoimmune responses. The
recent demonstration ofT-cell heterogene-
ity, including various functional pheno-
types of CD4+ cells (35-38), has led to
more refined dissections of the complex
regulatory network. In rats, peripheral T-
cells differ in their expression of various
membrane determinants, i.e., CD4, CD8,
QCA-1, Thy-1, CD45RC, and RT6.
Thus, combining these markers allows the
identification ofa large number ofpheno-
typically different subsets of peripheral T-
lymphocytes (39). Previous investigations
in our laboratory have demonstrated that
BN rats repeatedly injected with mercuric
chloride experience a relative decrease of
peripheral RT6.2+ T-lymphocytes and an
altered ratio ofRT6- to RT6+ T-cells (1/).
These changes coincide with the appear-
ance of circulating autoantibodies to renal
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antigens (e.g., laminin). In the present
study we extended our phenotypic analysis
to rats ofanother strain (LEW) and exam-
ined additional numbers ofBN rats as well
as F1 hybrids between BN and LEW.
We have confirmed that LEW and BN
rats differ in their responses to the admin-
istration of HgCI2. It was known that
LEW rats do not develop renal autoimmu-
nity after mercury treatment (4). How-
ever, there was no information on the be-
havior of RT6+ T-cells after exposure of
LEW rats to mercury, and it is of interest
that their percentage did not significantly
decrease. Numbers of RT6+ cells were
actually higher in both spleens and lymph
nodes of experimental rats, with increases
that reached statistical significance. In the
spleen, the ratio between RT6- and RT6+
T-lymphocytes showed a modest decrease
only on day 30, whereas in the lymph
nodes it was increased only on day 23, sug-
gesting that treatment with mercury did
not have consistent effects on this lympho-
cyte subpopulation. The lack of changes
in this natural balance may explain the
LEW resistance to the autoimmune effects
ofthis metal. On the other hand, we con-
firmed our initial findings that BN rats
injected with HgCl2 experience autoim-
mune responses to renal antigens as well as
a decrease in the percentage of RT6+ cells.
In spite of strikingly higher total numbers
ofspleen and lymph node cells, the num-
bers of RT6+ cells did not proportionally
increase, resulting in an altered balance
between RT6- and RT6+ T-lymphocytes
(Fig. 2). This mercury-induced effect is
quite similar to our previous results from
three different groups of BN rats, which
showed a definite decrease in the number
ofRT6+ spleen cells in one group and rela-
tive decreases in the other two (e.g., a 6%
increase versus controls, in spite of a 52%
increase in total cell numbers) (17). Dif-
ferences in total numbers of RT6 cells
between various groups ofBN rats seem to
depend on the magnitude of mercury-
induced splenomegaly and lymphadenopa-
thy, which vary considerably with age,
weight, and microbial status ofthe individ-
ual rats. However, percentage values of
RT6+ cells and ratios between negative and
positive cells are quite reproducible and
provide a reliable indication of the im-
munotoxic effects of mercury on this sub-
population ofBN rat lymphocytes.
We observed that F1 hybrid rats (i.e.,
hybrids between susceptible and resistant
rats), behaved like their BN parent strain
when exposed to mercury: they had both
renal autoimmunity and significantly lower
percentages of RT6+ T-lymphocytes. As
far as autoimmunity tO kidney antigens is
concerned, there was no detectable differ-
ence between BN and F1 rats (Table 1).
All animals had linear immunoglobulin de-
posits in their kidneys: previous work has
demonstrated that such deposits contain
antibodies to laminin and other renal anti-
gens (14,15). Antibodies to laminin and
rat GBM were also present in the sera of
most experimental rats. Flow cytometric
analysis showed that both RT6.1 and
RT6.2 surface markers are expressed on
lymphocytes of F1 rats. Control animals
had a higher percentage of RT6.2+ cells
than BN rats and a percentage of RT6.1+
cells similar to that of LEW (Tables 2 and
3). Previous studies by single-label im-
munofluorescence staining of lymph node
cells obtained from F1 hybrids between
Wistar Furth (RT6.2+) and diabetes-prone
or diabetes-resistant BB (RT6.1+) rats also
revealed the presence of RT6.1+ and
RT6.2+ lymphocytes in both hybrids (40).
Dual-label flow cytometric analysis ofthese
lymphocytes for RT6.1 and RT6.2 allo-
antigens has shown that the two molecules
are co-expressed on most of the cells. In
addition, those F1 hybrids had a higher
percentage of RT6.2+ than RT6.1+ cells,
which is confirmed by our findings in
hybrids between two additional rat strains.
The reasons for such a difference are
unknown but are probably related to the
epitope(s) recognized by the monoclonal
antibodies against RT6 alloantigens rather
than lack ofexpression of RT6.1 on some
RT6.2+ cells. In any case, experimental F
rats had a lower percentage ofboth RT6.1
and RT6.2+ cells in their spleens and
lymph nodes. Again, total numbers of
these cells were decreased in the spleen.
On the other hand, as previously observed
in BN rats, there was a relative decrease of
RT6+ cells in cervical lymph nodes, i.e.,
their number did not show the striking
increase observed in total cell numbers. As
a consequence, these changes resulted in an
altered balance within the RT6 T- lym-
phocyte population, as demonstrated by
the ratios between positive and negative
cells (Fig. 2).
Exposure to mercury had other im-
munotoxic effects on peripheral lymphoid
tissues (see Fig. 1). Total cell numbers
increased in the spleen and lymph nodes of
all experimental rats; however, the increase
was rather modest in LEW rats as com-
pared to that observed in BN rats.
Changes in the spleens ofFl hybrids were
intermediate between those ofthe parental
strains, whereas numbers in lymph nodes
were much higher. Other investigators
have previously reported that spleens and
lymph nodes were not much enlarged in
LEW rats injected with HgCI2 and there
were no major changes in totaf cell num-
bers (18,33,41). However, the modest
increases we observed may be easily
explained by differences in age and weight
of our LEW rats or the use of a different
substrain, possibly more susceptible to
mercury effects. The marked proliferation
of BN spleen and lymph node cells after
treatment with HgCl2 has been previously
noted by various investigators (17,18,32,
33,41). On the other hand, the lym-
phadenopathy and splenomegaly of F1 hy-
brids have not received much attention.
In addition to numerical increases of
spleen and lymph node cells, we also
noticed changes in most lymphocyte sub-
populations. For example, flow cytometry
of lymph nodes from experimental LEW
rats revealed a percentage decrease of B-
cells on day 12 and an increase on days 16
and 23. Parallel percentage changes ofIa'
cells were also observed on the same days.
The percentage of T-cells in the same
lymph nodes never varied significantly and
that of CD8+ cells was increased only on
day 23. In contrast, CD4+ cells differed
on each day of treatment, with a percent-
age increase on day 12 and decreases there-
after. Values for the spleen were more
constant, with the only significant percent-
age changes noted on day 30, when there
was a decrease of B- and Ia' cells. On the
other hand, total cell numbers ofalmost all
subsets were higher on days 12, 16, and 23
oftreatment, proportional to the moderate
increase in total cell numbers. Data for
experimental BN rats were obtained only
on day 16, i.e., at a time when their auto-
immune responses to renal antigens are at
their peak (17). B-cell percentages and
numbers were both higher than in con-
trols, whereas T-cell percentages de-creased
and numbers increased. Percentages and
numbers of CD8+ T-lymphocytes were
increased. In contrast, percentages of
CD4+ T-cells decreased and their numbers
increased. Almost identical changes were
observed in spleen and lymph nodes ob-
tained from F1 hybrids on day 16 oftreat-
ment with HgCl2.
Of particular interest is our finding
that both percentage and total numbers of
CD8+ T-lymphocytes did not show consis-
tent and significant increases in the spleens
of experimental LEW rats. In the lymph
nodes, CD8+ cells increased in percentage
only on day 23 and in total numbers only
on days 16 and 23, proportional to the
higher total cell numbers. In contrast,
experimental BN and Fl rats had increased
percentages as well as higher numbers of
these lymphocytes. These data show that
BN and F1 rats, at the peak of autoim-
mune responses induced by the adminis-
tration of mercury, have increased levels
(both as a percentage and numerically) of
CD8+ T-lymphocytes, whereas LEW rats,
resistant to the autoimmune effects ofthis
metal, usually show only numerical in-
creases. On this basis, it is difficult to
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attribute an immunosuppressive role to
CD8+ T-lymphocytes either in LEW or
BN rats. In earlier studies, Pelletier et al.
(18,20) observed significant increases in
both percentage and/or numbers of CD8+
T-cells in LEW rats on days 14, 28, and 35
of mercury treatment. The same group
reported that the administration of HgCI2
to LEW rats for 2 weeks before immuniza-
tion with certain autoantigens had im-
munosuppressive effects on the experimen-
tal induction of autoimmunity (e.g.,
Heymann's nephritis and EAE) (19,42).
As far as BN rats are concerned, sequential
studies of peripheral blood lymphocyte
populations during HgCI2 treatment have
shown a transient decrease in the percent-
age ofCD8+ T-cells before the appearance
of serum anti-GBM antibodies, followed
by elevated levels of these cells during
down-regulation of the response (43).
Aten et al. (32) also noted that CD8 levels
were higher in BN rats on day 21 than on
day 0. These observations led to the sug-
gestion that CD8+ cells, which at that time
were still defined as "suppressor/cytotoxic"
T-lymphocytes, might have an immuno-
regulatory role in both LEW and BN rats.
Differences in techniques of phenotypic
analysis and the use ofvarious substrains of
rats may explain the discrepancies between
the data available in the literature. In any
case, considerable doubts have later been
raised about the existence of T-suppressor
cells in general and the immunosuppressive
properties of CD8+ T-lymphocytes in par-
ticular. Our findings suggest that increases
of CD8+ T-cells may actually have no
major role in the lack of autoimmune
responses or the down-regulation of renal
autoimmunity observed in LEW and BN
rats, respectively, after mercury treatment.
Finally, our data underline the impor-
tance ofa complete and detailed phenotyp-
ic analysis of lymphoid cells in studies of
immunotoxicity and xenobiotic-induced
autoimmunity. Traditional markers such
as CD4 and CD8 may not be sufficient to
characterize different subpopulations ofT-
cells, in view of the heterogeneity demon-
strated by functional studies (38). The use
of additional surface markers (e.g., the
RT6 alloantigens) together with cytokine
profiles of T-cell clones may be necessary
for a better understanding ofimmunoregu-
latory processes. T-cells ofthe RT6 pheno-
type are known to be severely decreased in
spontaneously hyperglycemic diabetes-
prone BB/Wor rats, and their deficiency
may be an important predisposing factor in
susceptibility to insulin-dependent diabetes
mellitus. It has also been suggested that
RT6+ T-cells have a regulatory role in self-
tolerance (44). The parallel changes of
RT6+ T-lymphocytes observed in both BN
and F1 hybrids as well as the opposite
behavior detected in LEW rats also suggest
a regulatory role of RT6 lymphocytes.
The obvious question then arises: Are there
equivalents for the RT6 marker in hu-
mans? To our knowledge, none have been
reported to date. However, two recent
studies have shown an abnormally high
proportion of CD4+ T-cells of the
CD45RA+ phenotype in patients with
insulin-dependent diabetes mellitus or
mixed connective tissue disease (45,46).
These results still need to be confirmed,
and their functional significance remains
to be determined (47). However, they
suggest that phenotypic and functional
changes first observed in rat models of
autoimmunity may have similar, if not
identical, counterparts in human disease.
In conclusion, on the basis of the
results presented in this paper we propose
the hypothesis that there are both endoge-
nous and exogenous components of mer-
cury-induced autoimmunity. The first
component, genetically determined, con-
stitutes the "terrain" of the individuals
exposed to the xenobiotic and comprises
TCR, MHC, and an immunoregulatory
network based on a delicate balance be-
tween cells with suppressor (e.g., RT6+ T-
lymphocytes) and helper activities. The
exogenous component is represented by an
environmental factor, e.g., mercury, capa-
ble of altering the balance within the
immunoregulatory network. All these ele-
ments must be present and interact for
autoimmunity to occur. The rat models
described in this paper lend themselves to
experimental manipulations, currently
ongoing in our laboratory, to dissect the
role of these various components in auto-
immunity induced by mercury.
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